Distinct urinary glycoprotein signatures in prostate cancer patients

Novel biomarkers are needed to complement prostate specific antigen (PSA) in prostate cancer (PCa) diagnostic screening programs. Glycoproteins represent a hitherto largely untapped resource with a great potential as specific and sensitive tumor biomarkers due to their abundance in bodily fluids and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawahara, Rebeca, Ortega, Fabio, Rosa-Fernandes, Livia, Guimarães, Vanessa, Quina, Daniel, Nahas, Willian, Schwämmle, Veit, Srougi, Miguel, Leite, Katia R.M., Thaysen-Andersen, Morten, Larsen, Martin R., Palmisano, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145689/
https://www.ncbi.nlm.nih.gov/pubmed/30237853
http://dx.doi.org/10.18632/oncotarget.26005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145689/
https://www.ncbi.nlm.nih.gov/pubmed/30237853
http://dx.doi.org/10.18632/oncotarget.26005

Ejemplares similares